Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Autoradiographic Mapping of5-HT1B/1DBinding Sites in the Rhesus Monkey Brain Using [carbonyl-11C]zolmitriptan
View through CrossRef
Zolmitriptan is a serotonin5-HT1B/1Dreceptor agonist that is an effective and well-tolerated drug for migraine treatment. In a human positron emission tomography study, [11C]zolmitriptan crossed the blood-brain barrier but no clear pattern of regional uptake was discernable. The objective of this study was to map the binding of [11C]zolmitriptan in Rhesus monkey brain using whole hemispherein vitroautoradiography with [11C]zolmitriptan as a radioligand. In saturation studies, [11C]zolmitriptan showed specific (90%) binding to a population of high-affinity binding sites (Kd 0.95–5.06 nM). There was regional distribution of binding sites with the highest density in the ventral pallidum, followed by the external globus pallidus, substantia nigra, visual cortex, and nucleus accumbens. In competitive binding studies with 5-HT1receptor antagonists, [11C]zolmitriptan binding was blocked by selective 5-HT1Band 5-HT1Dligands in all target areas. There was no appreciable change in binding with the addition of a 5-HT1Areceptor antagonist.
Title: Autoradiographic Mapping of5-HT1B/1DBinding Sites in the Rhesus Monkey Brain Using [carbonyl-11C]zolmitriptan
Description:
Zolmitriptan is a serotonin5-HT1B/1Dreceptor agonist that is an effective and well-tolerated drug for migraine treatment.
In a human positron emission tomography study, [11C]zolmitriptan crossed the blood-brain barrier but no clear pattern of regional uptake was discernable.
The objective of this study was to map the binding of [11C]zolmitriptan in Rhesus monkey brain using whole hemispherein vitroautoradiography with [11C]zolmitriptan as a radioligand.
In saturation studies, [11C]zolmitriptan showed specific (90%) binding to a population of high-affinity binding sites (Kd 0.
95–5.
06 nM).
There was regional distribution of binding sites with the highest density in the ventral pallidum, followed by the external globus pallidus, substantia nigra, visual cortex, and nucleus accumbens.
In competitive binding studies with 5-HT1receptor antagonists, [11C]zolmitriptan binding was blocked by selective 5-HT1Band 5-HT1Dligands in all target areas.
There was no appreciable change in binding with the addition of a 5-HT1Areceptor antagonist.
Related Results
In-target Production of [11C]CH4 from a Nitrogen/Hydrogen Gas Target as a Function of Beam Current, Irradiation Time, and Target Temperature
In-target Production of [11C]CH4 from a Nitrogen/Hydrogen Gas Target as a Function of Beam Current, Irradiation Time, and Target Temperature
Abstract
Background
Production of [11C]CH4 from gas targets is notorious for weak performance with respect to yield, especially when using high beam currents. However, air...
Brain Organoids, the Path Forward?
Brain Organoids, the Path Forward?
Photo by Maxim Berg on Unsplash
INTRODUCTION
The brain is one of the most foundational parts of being human, and we are still learning about what makes humans unique. Advancements ...
Abstract 1646: Synthesis of [11C]onapristone for clinical investigation
Abstract 1646: Synthesis of [11C]onapristone for clinical investigation
Abstract
Background: Onapristone is a type I anti-progestin, which prevents the progesterone receptor (PR) monomers from dimerizing, inhibits ligand-induced phosphor...
In-target production of [11C]CH4 from a nitrogen/hydrogen gas target as a function of beam current, irradiation time, and target temperature
In-target production of [11C]CH4 from a nitrogen/hydrogen gas target as a function of beam current, irradiation time, and target temperature
Abstract
Background
Production of [11C]CH4 from gas targets is notorious for weak performance with respect to yield, especially when using high beam...
Receptor specificity and trigemino‐vascular inhibitory actions of a novel 5‐HT1B/1D receptor partial agonist, 311C90 (zolmitriptan)
Receptor specificity and trigemino‐vascular inhibitory actions of a novel 5‐HT1B/1D receptor partial agonist, 311C90 (zolmitriptan)
311C90 (zolmitriptan zomig: (S)‐4[[3‐[2‐(dimethylamino)ethyl]‐1H‐indol‐5‐yl]methyl]‐2‐oxazolidinone) is a novel 5‐HT1B/1D receptor agonist with proven efficacy in the acute treatme...
Hand Musculature of the Rhesus Monkey (Macaca mulatta): An Anatomical Study
Hand Musculature of the Rhesus Monkey (Macaca mulatta): An Anatomical Study
The rhesus monkey (Macaca mulatta) is one of the most frequently used primate species in biomedical research. As a common animal model used to study human disease, the validation o...
Characteristics and influencing factors of 11C-CFT PET imaging in patients with early and late onset Parkinson’s disease
Characteristics and influencing factors of 11C-CFT PET imaging in patients with early and late onset Parkinson’s disease
ObjectiveThis study aims to explore the difference between 11C-methyl-N-2β-carbomethoxy-3β-(4-fluorophenyl)-tropanel (11C-CFT) positron emission tomography (PET) imaging in the ear...
Implication of altered α7 nicotinic receptors and amyloid deposition in the Alzheimer's brain
Implication of altered α7 nicotinic receptors and amyloid deposition in the Alzheimer's brain
IntroductionBrain amyloid-β protein (Aβ) deposition is a key pathology of Alzheimer's disease (AD). Cholinergic degeneration, including reductions in α7 nicotinic acetylcholine rec...